Arch Pharmalabs
BSE: 524729 | NSE: N.A | ISIN: INE182F01017 | Pharmaceuticals
 |
Nine Months of Arch Pharmalabs |
------------------- in Rs. Cr. ------------------- |
| ||||||||
|
||||||||
| Dec '03 | Dec '04 | Dec '05 | ||||||
|
||||||||
| Sales Turnover | 68.05 | 116.01 | 169.75 | |||||
| Other Income | -0.03 | 0.16 | 0.37 | |||||
| Total Income | 68.02 | 116.16 | 170.11 | |||||
| Total Expenses | 55.29 | 94.33 | 136.66 | |||||
| Operating Profit | 12.76 | 21.68 | 33.09 | |||||
| Profit On Sale Of Assets | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | |||||
| Gross Profit | 12.73 | 21.84 | 33.46 | |||||
| Interest | 4.01 | 5.94 | 10.94 | |||||
| PBDT | 8.72 | 15.90 | 22.52 | |||||
| Depreciation | 0.79 | 2.17 | 6.60 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | |||||
| PBT | 7.93 | 13.73 | 15.92 | |||||
| Tax | -- | 4.10 | 4.25 | |||||
| Net Profit | 7.93 | 9.63 | 11.67 | |||||
| Prior Years Income/Expenses | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | |||||
| Dividend | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | |||||
| Earnings Per Share | 9.08 | 10.35 | 8.52 | |||||
| Book Value | -- | -- | -- | |||||
| Equity | 8.73 | 9.30 | 13.69 | |||||
| Reserves | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | |||||
| ||||||||
| Source : Religare Technova | ||||||||
| Explore Arch Pharmalabs connections | ||||||||
| ||||||||
